XML 92 R28.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Stock-Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2019
Share-based Payment Arrangement [Abstract] |
Stock-Based Compensation | NOTE 21 – Stock-Based Compensation Compensation cost is recognized for stock options and restricted stock awards issued to employees and non-employee directors. Compensation cost is measured as the fair value of these awards on their date of grant. A Black-Scholes model is utilized to estimate the fair value of stock options, while the market price of the Company’s common stock at the date of grant is used as the fair value of restricted stock awards. Compensation cost is recognized over the required service period, generally defined as the vesting period for stock option and restricted stock awards. The Company’s stock incentive programs are long-term retention programs intended to attract, retain, and provide incentives for key employees and non-employee directors in the form of incentive and non-qualified stock options and restricted stock. Stock-based compensation expense was recorded as follows:
|  | For the years ended December 31,
(dollars in thousands) |  | 2019 |  | 2018 |  | 2017
Stock option expense |  | $ | 1,270 |  | 1,183 |  | 959
Restricted stock grant expense |  |  | 428 |  | 319 |  | 299
Total stock-based compensation expense |  | $ | 1,698 |  | 1,502 |  | 1,258
Stock Options On May 18, 2010, the Company adopted the 2010 Incentive Plan, making available for issuance 366,025 stock options (adjusted for the 10% stock dividends in 2013, 2012, and 2011). The options may be exercised at an exercise price per share based on the fair market value and determined on the date of grant and expire 10 years from the grant date. On May 20, 2014, the Company amended the 2010 Incentive Plan to add an additional 200,000 shares of common stock to be issuable as stock options, for a total of 566,025 shares. As of December 31, 2019, there were 9,275 options available for grant under the 2010 Incentive Plan. On May 17, 2016, the Company adopted the 2016 Equity Incentive Plan, making available for issuance 400,000 stock options. The options may be exercised at an exercise price per share based on the fair market value and determined on the date of grant and expire 10 years from the grant date. As of December 31, 2019, there were 174,715 options available for grant under the 2016 Equity Incentive Plan. A summary of the status of the stock option plan and changes for the period is presented below:
|  | For the years ended December 31,
|  |  |  |  |  |  |  | 2019 |  |  |  |  |  |  |  | 2018 |  |  |  |  |  |  |  | 2017
|  |  |  |  |  |  |  | Weighted |  |  |  |  |  |  |  | Weighted |  |  |  |  |  |  |  | Weighted
|  |  |  |  | Weighted |  | Average |  |  |  |  | Weighted |  | Average |  |  |  |  | Weighted |  | Average
|  |  |  |  | average |  | Remaining |  |  |  |  | average |  | Remaining |  |  |  |  | average |  | Remaining
|  |  |  |  | exercise |  | Contractual |  |  |  |  | exercise |  | Contractual |  |  |  |  | exercise |  | Contractual
|  | Shares |  |  | price |  | Life |  | Shares |  |  | price |  | Life |  | Shares |  |  | price |  | Life
Outstanding at beginning of year |  | 648,311 |  |  | $ | 20.74 |  |  |  | 662,841 |  |  | $ | 15.70 |  |  |  | 642,203 |  |  | $ | 11.77 |  |
Granted |  | 101,350 |  |  |  | 32.81 |  |  |  | 94,700 |  |  |  | 43.13 |  |  |  | 110,950 |  |  |  | 35.34 |  |
Exercised |  | (191,497 | ) |  |  | 9.24 |  |  |  | (105,630 | ) |  |  | 8.51 |  |  |  | (74,437 | ) |  |  | 9.48 |  |
Forfeited or expired |  | (16,750 | ) |  |  | 34.01 |  |  |  | (3,600 | ) |  |  | 40.03 |  |  |  | (15,875 | ) |  |  | 23.49 |  |
Outstanding at end of year |  | 541,414 |  |  | $ | 26.65 |  | 6.3 years |  | 648,311 |  |  | $ | 20.74 |  | 5.6 years |  | 662,841 |  |  | $ | 15.70 |  | 5.6 years
Options exercisable at year-end |  | 305,991 |  |  | $ | 20.00 |  | 4.9 years |  | 404,851 |  |  | $ | 12.58 |  | 4.0 years |  | 419,766 |  |  | $ | 9.20 |  | 4.1 years
Weighted average fair value of options granted during the year |  |  |  |  | $ | 11.81 |  |  |  |  |  |  | $ | 16.76 |  |  |  |  |  |  | $ | 14.14 |  |
Shares available for grant |  | 183,990 |  |  |  |  |  |  |  | 270,090 |  |  |  |  |  |  |  | 359,690 |  |  |  |  |  |
The aggregate intrinsic value (the difference between the Company’s closing stock price on the last trading day of the year and the exercise price, multiplied by the number of in-the-money options) of 541,414 and 648,311 stock options outstanding at December 31, 2019 and 2018 was $8.6 million and $8.7 million, respectively. The aggregate intrinsic value of 305,991 and 404,851 stock options exercisable at December 31, 2019 and 2018 was $6.9 million and $8.0 million, respectively. The fair value of the option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The following assumptions were used for grants:
|  | 2019 |  | 2018 |  | 2017
Dividend yield |  | - |  | - |  | -
Expected life |  | 7 years |  | 7 years |  | 7 years
Expected volatility |  | 28.21% |  | 32.07% |  | 34.63%
Risk-free interest rate |  | 2.59% |  | 2.50% |  | 2.04%
At December 31, 2019, there was $2.0 million of total unrecognized compensation cost related to nonvested stock option grants. The cost is expected to be recognized over a weighted-average period of 2.4 years. The fair value of stock option grants that vested during 2019, 2018, and 2017 was $1.2 million, $973,000 and $775,000, respectively. Restricted Stock Grants On May 17, 2016, the Company adopted the 2016 Equity Incentive Plan which included a provision for the issuance of 50,000 shares of common stock to be issuable as restricted stock grants. As of December 31, 2019, 32,349 shares of restricted stock were available for grant. Shares of restricted stock granted to employees under the stock plans are subject to restrictions as to continuous employment for a specified time period following the date of grant. During this period, the holder is entitled to full voting rights and dividends. A summary of the status of the Company’s nonvested restricted stock and changes for the years ended December 31, 2019, 2018, and 2017 is as follows:
|  | December 31,
|  |  |  |  | 2019 |  |  |  |  | 2018 |  |  |  |  | 2017
|  |  |  |  | Weighted |  |  |  |  | Weighted |  |  |  |  | Weighted
|  |  |  |  | Average |  |  |  |  | Average |  |  |  |  | Average
|  | Restricted |  |  | Grant-Date |  | Restricted |  |  | Grant-Date |  | Restricted |  |  | Grant-Date
|  | Shares |  |  | Fair Value |  | Shares |  |  | Fair Value |  | Shares |  |  | Fair Value
Nonvested at beginning of year |  | 29,625 |  |  | $ | 34.00 |  | 25,000 |  |  | $ | 26.43 |  | 36,125 |  |  | $ | 20.13
Granted |  | 14,700 |  |  |  | 33.64 |  | 13,000 |  |  |  | 42.87 |  | 6,500 |  |  |  | 35.14
Vested |  | (10,375 | ) |  |  | 31.61 |  | (8,375 | ) |  |  | 25.17 |  | (17,625 | ) |  |  | 16.73
Forfeited |  | (1,125 | ) |  |  | 28.03 |  | - |  |  |  | - |  | - |  |  |  | -
Nonvested at end of year |  | 32,825 |  |  | $ | 34.78 |  | 29,625 |  |  | $ | 34.00 |  | 25,000 |  |  | $ | 26.43
At December 31, 2019, there was $793,000 of total unrecognized compensation cost related to nonvested restricted stock grants. The cost is expected to be recognized over a weighted-average period of 2.6 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration